Monoclonals and Migraine: What the Primary Care Physician Needs to Know
Monoclonal antibodies that inhibit calcitonin gene-related peptide could revolutionize preventive migraine therapy. Here's what you need to know.
Hormones and Migraine: A Case Study
Headaches that occur several days before menses as well as disabling headaches on days unrelated to menses... how would you help this young woman?
Pediatric and Adolescent Migraine: Update on Treatment Options
If the goal of headache therapy for adolescent migraineurs is a pain-free adult life, here's a road map.
Migraine Patients Need to Hear: It’s Physiologic and Treatable
From PAINWeek 2017: Reflex vasodilation is out, neurobiologic dysfunction is in as explanation for migraine etiology.
What's New In Migraine Therapy: An Update for Primary Care
What Rx for adolescent migraineurs? Ideal care for menstrual migraine? Perfect patient for new CGRP inhibitors? Answers in this PCP Special Report.
Get On Top of Headaches: 10 New Findings
Headache was a hot topic at the AAN Annual Meeting, and several studies have added to the literature. This slideshow summarizes the latest.
"BOTOX for Migraines?"
If you know that the FDA approved onabotulinumtoxinA to treat chronic migraine headache but aren't sure how it works, a neurologist explains.
Migraine: Keeping the Beast at Bay
Do you know what drugs current guidelines recommend? Get an 8-slide update, here.
Top 10 Reasons Why Patients Come to Primary Care
What brings patients to your office—and not the specialty office down the street? Insights in this slideshow.
Triptans and Ergotamines: What’s the CV Risk?
Triptan and ergotamine drugs are staples of acute migraine treatment. But questions about their cardiovascular safety linger in the absence of clear evidence. A short slide show looks at what we do know.
By clicking Accept, you agree to become a member of the UBM Medica Community.